After a soft start to the day, the ASX bounced back and closed the day 0.3% higher on Monday, with mixed results across the ...

The Jewish Federation of Greater Dallas (JFGD) announced the launch of its newly redesigned website, developed in partnership with agency of record Tegan Digital. The new website represents a major ...

In our 'Marketing Excellence' themed month Sunil Ramkali discusses how to deliver an effective pharmaceutical global strategic brand plan. Developing your global strategic brand and tactical plan ...

and Stella Pharma, the pioneering developer of boronophenylalanine (BPA) under the product name Steboronine® for BNCT, are pleased to announce a strategic collaboration focused on the development ...

Inc. is a pharmaceutical company specializing in the development of innovative cancer therapies, focusing on acquiring and advancing promising cancer agents through strategic partnerships and ...

Leerink Partners analyst Mani Foroohar maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) on November 12 and set a ...

The Nippon India Pharma Fund - Direct Plan - Growth Plan has an AUM of 8768.67 crores & has delivered CAGR of 30.96% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of ...

Ascendis Pharma (ASND) has released an update ... Investors might find the company’s strategic initiatives and financial performance promising as it aims for significant market impact in ...

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries ...

Jacobson Pharma Corporation Limited (HK ... This transaction reflects strategic intra-group asset management within the company’s subsidiaries. TipRanks is the most comprehensive data set ...

a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to the escalating ...

a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to the escalating demand ...